Literature DB >> 2379540

Excretion of tolbutamide metabolites in young and old subjects.

A K Miller1, J Adir, R E Vestal.   

Abstract

Tolbutamide (1 g/70 kg) was administered as a single intravenous dose to 31 healthy, non-smoking, drug-free males between 23 and 87 years old and the total amounts of hydroxy and carboxytolbutamide excreted in 24 h were measured. There was a significant decrease in the urinary recovery of both metabolites with age. The reason for these findings is not known at the present time and may be associated with the decrease in creatinine clearance observed in these subjects or other changes in the pharmacokinetics of tolbutamide which are currently being investigated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2379540     DOI: 10.1007/bf02336696

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study.

Authors:  J W Rowe; R Andres; J D Tobin; A H Norris; N W Shock
Journal:  J Gerontol       Date:  1976-03

Review 2.  Drug metabolism in the elderly.

Authors:  C M Loi; R E Vestal
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

3.  Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program.

Authors:  D J Greenblatt
Journal:  J Am Geriatr Soc       Date:  1979-01       Impact factor: 5.562

4.  Tolbutamide binding to plasma proteins of young and old human subjects.

Authors:  A K Miller; J Adir; R E Vestal
Journal:  J Pharm Sci       Date:  1978-08       Impact factor: 3.534

5.  The metabolic fate of tolbutamide in man and in the rat.

Authors:  R C Thomas; G J Ikeda
Journal:  J Med Chem       Date:  1966-07       Impact factor: 7.446

Review 6.  Pharmacokinetics in the elderly.

Authors:  J Crooks; K O'Malley; I H Stevenson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

7.  Effects of total plasma concentration and age on tolbutamide plasma protein binding.

Authors:  J Adir; A K Miller; R E Vestal
Journal:  Clin Pharmacol Ther       Date:  1982-04       Impact factor: 6.875

  7 in total
  3 in total

Review 1.  The use of sulphonylureas in the elderly.

Authors:  M B Graal; B H Wolffenbuttel
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

2.  Physiologically-Based Pharmacokinetic Modeling Combined with Swiss HIV Cohort Study Data Supports No Dose Adjustment of Bictegravir in Elderly Individuals Living With HIV.

Authors:  Felix Stader; Perrine Courlet; Laurent A Decosterd; Manuel Battegay; Catia Marzolini
Journal:  Clin Pharmacol Ther       Date:  2021-02-27       Impact factor: 6.875

3.  Physiologically Based Pharmacokinetic Modelling of Cytochrome P450 2C9-Related Tolbutamide Drug Interactions with Sulfaphenazole and Tasisulam.

Authors:  Everett J Perkins; Maria Posada; P Kellie Turner; Jill Chappell; Wee Teck Ng; Chris Twelves
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-06       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.